{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:26:35Z","timestamp":1794367595985,"version":"4.9.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,12,15]]},"abstract":"<jats:p>Epstein-Barr virus (EBV) is associated with B-cell lymphomas such as Hodgkin lymphoma, Burkitt lymphoma, and post-transplantation lymphoma, which originate from clonal germinal center (GC) B cells. During the process of somatic hypermutation, GC B cells can acquire deleterious or nonsense mutations in the heavy and light immunoglobulin genes. Such mutations abrogate the cell surface expression of the B-cell receptor (BCR), which results in the elimination of these nonfunctional B cells by immediate apoptosis. EBV encodes several latent genes, among them latent membrane protein 1 (LMP1) and LMP2A, which are regularly expressed in EBV-positive Hodgkin lymphoma and posttransplantation lymphomas. Since LMP1 and LMP2A mimic the function of 2 key receptors on B cells, CD40 and BCR, respectively, we wanted to learn whether EBV infection can rescue proapoptotic GC B cells with crippling mutations in the heavy chain immunoglobulin locus from apoptosis. We show here that BCR-negative GC B cells readily enter the cell cycle upon infection with EBV in vitro and yield clonal lymphoblastoid cell lines that are incapable of expressing a functional BCR because the rearranged and formerly functional heavy chain immunoglobulin alleles carry deleterious mutations. Our findings imply an important role for EBV in the process of lymphomagenesis in certain cases of Hodgkin lymphoma and posttransplantation lymphomas.<\/jats:p>","DOI":"10.1182\/blood-2005-06-2341","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T22:33:11Z","timestamp":1123021991000},"page":"4339-4344","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":164,"title":["Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus"],"prefix":"10.1182","volume":"106","author":[{"given":"Christoph","family":"Mancao","sequence":"first","affiliation":[{"name":"From the GSF-National Research Center for Environment and Health and the Department of Gene Vectors; and the Institute for Clinical Molecular Biology and Tumor Genetics, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Altmann","sequence":"additional","affiliation":[{"name":"From the GSF-National Research Center for Environment and Health and the Department of Gene Vectors; and the Institute for Clinical Molecular Biology and Tumor Genetics, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Jungnickel","sequence":"additional","affiliation":[{"name":"From the GSF-National Research Center for Environment and Health and the Department of Gene Vectors; and the Institute for Clinical Molecular Biology and Tumor Genetics, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hammerschmidt","sequence":"additional","affiliation":[{"name":"From the GSF-National Research Center for Environment and Health and the Department of Gene Vectors; and the Institute for Clinical Molecular Biology and Tumor Genetics, Munich, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111816083104200_REF1","doi-asserted-by":"crossref","unstructured":"Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan IC. Mechanism of antigen-driven selection in germinal centres. Nature. 1989;342: 929-931.","DOI":"10.1038\/342929a0"},{"key":"2019111816083104200_REF2","doi-asserted-by":"crossref","unstructured":"Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha\/beta heterodimer. Cell. 2004;117: 787-800.","DOI":"10.1016\/j.cell.2004.05.014"},{"key":"2019111816083104200_REF3","doi-asserted-by":"crossref","unstructured":"Marafioti T, Hummel M, Foss HD, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95: 1443-1450.","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450"},{"key":"2019111816083104200_REF4","doi-asserted-by":"crossref","unstructured":"Bra\u0308uninger A, Ku\u0308ppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A. 1997;94: 9337-9342.","DOI":"10.1073\/pnas.94.17.9337"},{"key":"2019111816083104200_REF5","doi-asserted-by":"crossref","unstructured":"Kanzler H, Ku\u0308ppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184: 1495-1505.","DOI":"10.1084\/jem.184.4.1495"},{"key":"2019111816083104200_REF6","unstructured":"Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, Griffin DE, Straus SE, eds. Fields' Virology. Vol 2. 4th ed. Philadelphia, PA: Lippincott-Williams & Wilkins; 2001: 2511-2573."},{"key":"2019111816083104200_REF7","doi-asserted-by":"crossref","unstructured":"Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A. 1991;88: 4766-4770.","DOI":"10.1073\/pnas.88.11.4766"},{"key":"2019111816083104200_REF8","doi-asserted-by":"crossref","unstructured":"Niedobitek G, Kremmer E, Herbst H, et al. Immunohistochemical detection of the Epstein-Barr virus\u2013encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood. 1997;90: 1664-1672.","DOI":"10.1182\/blood.V90.4.1664"},{"key":"2019111816083104200_REF9","doi-asserted-by":"crossref","unstructured":"Brink AA, Dukers DF, van den Brule AJ, et al. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. J Clin Pathol. 1997;50: 911-918.","DOI":"10.1136\/jcp.50.11.911"},{"key":"2019111816083104200_REF10","doi-asserted-by":"crossref","unstructured":"Kilger E, Kieser A, Baumann M, Hammerschmidt W. Epstein-Barr virus\u2013mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 1998;17: 1700-1709.","DOI":"10.1093\/emboj\/17.6.1700"},{"key":"2019111816083104200_","doi-asserted-by":"crossref","unstructured":"Hammerschmidt W, Sugden B. Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease. Trends Mol Med. 2004;10: 331-336.","DOI":"10.1016\/j.molmed.2004.05.006"},{"key":"2019111816083104200_REF12","doi-asserted-by":"crossref","unstructured":"Gires O, Zimber-Strobl U, Gonnella R, et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 1997;16: 6131-6140.","DOI":"10.1093\/emboj\/16.20.6131"},{"key":"2019111816083104200_REF13","doi-asserted-by":"crossref","unstructured":"Fruehling S, Longnecker R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology. 1997;235: 241-251.","DOI":"10.1006\/viro.1997.8690"},{"key":"2019111816083104200_REF14","doi-asserted-by":"crossref","unstructured":"Reth M. Antigen receptor tail clue. Nature. 1989;338: 383-384.","DOI":"10.1038\/338383b0"},{"key":"2019111816083104200_REF15","doi-asserted-by":"crossref","unstructured":"Cambier JC. Antigen and Fc receptor signaling: the awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol. 1995;155: 3281-3285.","DOI":"10.4049\/jimmunol.155.7.3281"},{"key":"2019111816083104200_REF16","doi-asserted-by":"crossref","unstructured":"Caldwell RG, Wilson JB, Anderson SJ, Longnecker R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity. 1998;9: 405-411.","DOI":"10.1016\/S1074-7613(00)80623-8"},{"key":"2019111816083104200_REF17","doi-asserted-by":"crossref","unstructured":"Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A. 1998;95: 8245-8250.","DOI":"10.1073\/pnas.95.14.8245"},{"key":"2019111816083104200_REF18","doi-asserted-by":"crossref","unstructured":"Dirmeier U, Hoffmann R, Kilger E, et al. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene. 2005;24: 1711-1717.","DOI":"10.1038\/sj.onc.1208367"},{"key":"2019111816083104200_REF19","doi-asserted-by":"crossref","unstructured":"Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science. 1991;251: 70-72.","DOI":"10.1126\/science.1702555"},{"key":"2019111816083104200_REF20","doi-asserted-by":"crossref","unstructured":"Ku\u0308ppers R. Molecular single-cell PCR analysis of rearranged immunoglobulin genes as a tool to determine the clonal composition of normal and malignant human B cells. In: Gu H, Rajewsky K, eds. Methods Molecular Biology. Vol 271. Totowa, NJ: Humana Press; 2004: 225-238.","DOI":"10.1385\/1-59259-796-3:225"},{"key":"2019111816083104200_REF21","doi-asserted-by":"crossref","unstructured":"Mu\u0308schen M, Rajewsky K, Bra\u0308uninger A, et al. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med. 2000;191: 387-394.","DOI":"10.1084\/jem.191.2.387"},{"key":"2019111816083104200_REF22","doi-asserted-by":"crossref","unstructured":"Zimber-Strobl U, Kempkes B, Marschall G, et al. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J. 1996;15: 7070-7078.","DOI":"10.1002\/j.1460-2075.1996.tb01098.x"},{"key":"2019111816083104200_REF23","doi-asserted-by":"crossref","unstructured":"Thomas RK, Re D, Wolf J, Diehl V. Part I: Hodgkin's lymphoma\u2013molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol. 2004;5: 11-18.","DOI":"10.1016\/S1470-2045(03)01319-6"},{"key":"2019111816083104200_REF24","doi-asserted-by":"crossref","unstructured":"Ku\u0308ppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol. 2003;3: 801-812.","DOI":"10.1038\/nri1201"},{"key":"2019111816083104200_REF25","doi-asserted-by":"crossref","unstructured":"Katamine S, Otsu M, Tada K, et al. Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements. Nature. 1984;309: 369-372.","DOI":"10.1038\/309369a0"},{"key":"2019111816083104200_","doi-asserted-by":"crossref","unstructured":"Hansson M, Falk K, Ernberg I. Epstein-Barr virus transformation of human pre-B cells. J Exp Med. 1983;158: 616-622.","DOI":"10.1084\/jem.158.2.616"},{"key":"2019111816083104200_REF27","doi-asserted-by":"crossref","unstructured":"Gregory CD, Kirchgens C, Edwards CF, et al. Epstein-Barr virus\u2013transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes. Eur J Immunol. 1987;17: 1199-1207.","DOI":"10.1002\/eji.1830170818"},{"key":"2019111816083104200_REF28","doi-asserted-by":"crossref","unstructured":"Ehlin-Henriksson B, Gordon J, Klein G. B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression. Immunology. 2003;108: 427-430.","DOI":"10.1046\/j.1365-2567.2003.01601.x"},{"key":"2019111816083104200_REF29","doi-asserted-by":"crossref","unstructured":"Mangeney M, Richard Y, Coulaud D, Tursz T, Wiels J. CD77: an antigen of germinal center B cells entering apoptosis. Eur J Immunol. 1991;21: 1131-1140.","DOI":"10.1002\/eji.1830210507"},{"key":"2019111816083104200_REF30","doi-asserted-by":"crossref","unstructured":"Lebecque S, de Bouteiller O, Arpin C, Banchereau J, Liu YJ. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J Exp Med. 1997;185: 563-571.","DOI":"10.1084\/jem.185.3.563"},{"key":"2019111816083104200_REF31","doi-asserted-by":"crossref","unstructured":"Zarnegar B, He JQ, Oganesyan G, Hoffmann A, Baltimore D, Cheng G. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc Natl Acad Sci U S A. 2004;101: 8108-8113.","DOI":"10.1073\/pnas.0402629101"},{"key":"2019111816083104200_REF32","doi-asserted-by":"crossref","unstructured":"Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381: 751-758.","DOI":"10.1038\/381751a0"},{"key":"2019111816083104200_REF33","doi-asserted-by":"crossref","unstructured":"Merchant M, Swart R, Katzman RB, et al. The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function. Int Rev Immunol. 2001;20: 805-835.","DOI":"10.3109\/08830180109045591"},{"key":"2019111816083104200_REF34","doi-asserted-by":"crossref","unstructured":"Casola S, Otipoby KL, Alimzhanov M, et al. B cell receptor signal strength determines B cell fate. Nat Immunol. 2004;5: 317-327.","DOI":"10.1038\/ni1036"},{"key":"2019111816083104200_REF35","doi-asserted-by":"crossref","unstructured":"Muschen M, Rajewsky K, Brauninger A, et al. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med. 2000;191: 387-394.","DOI":"10.1084\/jem.191.2.387"},{"key":"2019111816083104200_REF36","doi-asserted-by":"crossref","unstructured":"Kuppers R. Molecular biology of Hodgkin's lymphoma. Adv Cancer Res. 2002;84: 277-312.","DOI":"10.1016\/S0065-230X(02)84009-X"},{"key":"2019111816083104200_REF37","doi-asserted-by":"crossref","unstructured":"Martin JM, Veis D, Korsmeyer SJ, Sugden B. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J Virol. 1993;67: 5269-5278.","DOI":"10.1128\/JVI.67.9.5269-5278.1993"},{"key":"2019111816083104200_","doi-asserted-by":"crossref","unstructured":"Allday MJ, Crawford DH, Griffin BE. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol. 1989;70: 1755-1764.","DOI":"10.1099\/0022-1317-70-7-1755"},{"key":"2019111816083104200_REF39","doi-asserted-by":"crossref","unstructured":"Alfieri C, Birkenbach M, Kieff E. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 1991;181: 595-608.","DOI":"10.1016\/0042-6822(91)90893-G"},{"key":"2019111816083104200_REF40","unstructured":"Altmann M, Hammerschmidt W. Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol. In press."},{"key":"2019111816083104200_REF41","doi-asserted-by":"crossref","unstructured":"Bechtel D, Kurth J, Unkel C, Kuppers R. Transformation of BCR-deficient germinal center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and post transplant lymphoma. Blood. Prepublished on August 30, 2005, as DOI 10.1182\/blood-2005-06-2342.","DOI":"10.1182\/blood-2005-06-2342"},{"key":"2019111816083104200_REF42","doi-asserted-by":"crossref","unstructured":"Chaganti S, Bell AI, Begue-Pastor N, et al. Epstein-Barr virus infection in vitro can rescue germinal centre B cells with inactivated immunoglobulin genes. Blood. Prepublished on August 25, 2005, as DOI 10.1182\/blood-2005-06-2327.","DOI":"10.1182\/blood-2005-06-2327"},{"key":"2019111816083104200_REF43","doi-asserted-by":"crossref","unstructured":"Deacon EM, Pallesen G, Niedobitek G, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med. 1993;177: 339-349.","DOI":"10.1084\/jem.177.2.339"},{"key":"2019111816083104200_REF44","doi-asserted-by":"crossref","unstructured":"Grasser FA, Murray PG, Kremmer E, et al. Monoclonal antibodies directed against the Epstein-Barr virus\u2013encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood. 1994;84: 3792-3798.","DOI":"10.1182\/blood.V84.11.3792.bloodjournal84113792"},{"key":"2019111816083104200_REF45","doi-asserted-by":"crossref","unstructured":"Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 1991;337: 320-322.","DOI":"10.1016\/0140-6736(91)90943-J"},{"key":"2019111816083104200_REF46","doi-asserted-by":"crossref","unstructured":"Babcock GJ, Hochberg D, Thorley-Lawson AD. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity. 2000;13: 497-506.","DOI":"10.1016\/S1074-7613(00)00049-2"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/13\/4339\/465188\/zh802405004339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/13\/4339\/465188\/zh802405004339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T19:43:33Z","timestamp":1683143013000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/13\/4339\/133269\/Rescue-of-crippled-germinal-center-B-cells-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,15]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2005,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-06-2341","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,15]]}}}